nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—SLC22A5—Dactinomycin—ocular cancer	0.828	1	CbGbCtD
Dopamine—HTR7—Circadian rythm related genes—TP53—ocular cancer	0.000165	0.000957	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—GNAQ—ocular cancer	0.000165	0.000956	CbGpPWpGaD
Dopamine—SLC22A2—Neuronal System—MDM2—ocular cancer	0.000163	0.000946	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—GNA11—ocular cancer	0.000163	0.000946	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—GNA11—ocular cancer	0.000161	0.000937	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—E2F5—ocular cancer	0.000161	0.000936	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TFDP1—ocular cancer	0.000161	0.000936	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PSPH—ocular cancer	0.000161	0.000935	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—GNA11—ocular cancer	0.000161	0.000933	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PSPH—ocular cancer	0.00016	0.000927	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—E2F4—ocular cancer	0.000158	0.000917	CbGpPWpGaD
Dopamine—DRD4—Circadian rythm related genes—TP53—ocular cancer	0.000158	0.000916	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—GNA11—ocular cancer	0.000157	0.000912	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—RBL1—ocular cancer	0.000155	0.000899	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—GNA11—ocular cancer	0.000154	0.000896	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TFDP1—ocular cancer	0.000154	0.000896	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—E2F5—ocular cancer	0.000154	0.000895	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SAG—ocular cancer	0.000153	0.000888	CbGpPWpGaD
Dopamine—SLC22A1—Neuronal System—MDM2—ocular cancer	0.000152	0.000882	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—GNAQ—ocular cancer	0.000152	0.00088	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—E2F4—ocular cancer	0.000151	0.000877	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—GNAQ—ocular cancer	0.00015	0.000871	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—EP300—ocular cancer	0.00015	0.00087	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—GNAQ—ocular cancer	0.00015	0.000868	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—E2F3—ocular cancer	0.000149	0.000867	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—RBL1—ocular cancer	0.000148	0.00086	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—E2F3—ocular cancer	0.000147	0.000856	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—GNA11—ocular cancer	0.000147	0.000851	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—GNAQ—ocular cancer	0.000146	0.000848	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—GNA11—ocular cancer	0.000145	0.000841	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—GNAQ—ocular cancer	0.000144	0.000833	CbGpPWpGaD
Dopamine—DRD1—Circadian rythm related genes—TP53—ocular cancer	0.000142	0.000825	CbGpPWpGaD
Dopamine—DRD3—Circadian rythm related genes—TP53—ocular cancer	0.00014	0.000814	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—GNA11—ocular cancer	0.00014	0.000814	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TFDP1—ocular cancer	0.000139	0.000806	CbGpPWpGaD
Dopamine—MAOA—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000138	0.000801	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TFDP1—ocular cancer	0.000137	0.000796	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PSPH—ocular cancer	0.000137	0.000792	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—GNAQ—ocular cancer	0.000136	0.000791	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—GNA11—ocular cancer	0.000136	0.000787	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—E2F5—ocular cancer	0.000135	0.000786	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—GNAQ—ocular cancer	0.000135	0.000782	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—E2F3—ocular cancer	0.000134	0.00078	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—E2F4—ocular cancer	0.000133	0.00077	CbGpPWpGaD
Dopamine—DBH—Metabolism—EP300—ocular cancer	0.000132	0.000769	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—GNAQ—ocular cancer	0.00013	0.000756	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RBL1—ocular cancer	0.00013	0.000755	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—E2F3—ocular cancer	0.000129	0.000746	CbGpPWpGaD
Dopamine—SLC6A3—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000128	0.000745	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MAML2—ocular cancer	0.000128	0.000743	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—GNAQ—ocular cancer	0.000126	0.000731	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TFDP1—ocular cancer	0.000125	0.000725	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—GNA11—ocular cancer	0.000123	0.000714	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MAML2—ocular cancer	0.000123	0.000712	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HDAC1—ocular cancer	0.000121	0.000705	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TFDP1—ocular cancer	0.000119	0.000693	CbGpPWpGaD
Dopamine—SLC22A2—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000117	0.000678	CbGpPWpGaD
Dopamine—MAOA—Metabolism—GNA11—ocular cancer	0.000116	0.000676	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—GNAQ—ocular cancer	0.000114	0.000664	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—E2F3—ocular cancer	0.000113	0.000655	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—GNA11—ocular cancer	0.000112	0.000649	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MAML2—ocular cancer	0.00011	0.000641	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MAML2—ocular cancer	0.000109	0.000632	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CDKN2B—ocular cancer	0.000109	0.000632	CbGpPWpGaD
Dopamine—SLC22A1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000109	0.000632	CbGpPWpGaD
Dopamine—MAOA—Metabolism—GNAQ—ocular cancer	0.000108	0.000629	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—TP53—ocular cancer	0.000107	0.000623	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—GNA11—ocular cancer	0.000107	0.000621	CbGpPWpGaD
Dopamine—MAOA—Neuronal System—HRAS—ocular cancer	0.000106	0.000614	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TFDP1—ocular cancer	0.000105	0.000609	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—GNAQ—ocular cancer	0.000104	0.000603	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—E2F1—ocular cancer	9.99e-05	0.00058	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—GNAQ—ocular cancer	9.94e-05	0.000577	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MAML2—ocular cancer	9.92e-05	0.000576	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—GNA11—ocular cancer	9.85e-05	0.000572	CbGpPWpGaD
Dopamine—SLC6A3—Neuronal System—HRAS—ocular cancer	9.83e-05	0.000571	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—GNA11—ocular cancer	9.63e-05	0.000559	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—GNA11—ocular cancer	9.5e-05	0.000551	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MAML2—ocular cancer	9.49e-05	0.000551	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HDAC1—ocular cancer	9.36e-05	0.000543	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—GNA11—ocular cancer	9.18e-05	0.000533	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—GNAQ—ocular cancer	9.16e-05	0.000532	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HDAC1—ocular cancer	8.96e-05	0.00052	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—GNAQ—ocular cancer	8.95e-05	0.00052	CbGpPWpGaD
Dopamine—SLC22A2—Neuronal System—HRAS—ocular cancer	8.95e-05	0.000519	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—GNAQ—ocular cancer	8.83e-05	0.000513	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—GNA11—ocular cancer	8.66e-05	0.000502	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—GNAQ—ocular cancer	8.54e-05	0.000495	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CDKN2B—ocular cancer	8.39e-05	0.000487	CbGpPWpGaD
Dopamine—SLC22A1—Neuronal System—HRAS—ocular cancer	8.34e-05	0.000484	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAML2—ocular cancer	8.33e-05	0.000484	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—GNA11—ocular cancer	8.28e-05	0.000481	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HDAC1—ocular cancer	8.07e-05	0.000468	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—GNAQ—ocular cancer	8.05e-05	0.000467	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CDKN2B—ocular cancer	8.04e-05	0.000466	CbGpPWpGaD
Dopamine—DBH—Metabolism—AKT1—ocular cancer	8.01e-05	0.000465	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HDAC1—ocular cancer	7.96e-05	0.000462	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—E2F1—ocular cancer	7.7e-05	0.000447	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—GNAQ—ocular cancer	7.7e-05	0.000447	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—E2F1—ocular cancer	7.38e-05	0.000428	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—GNA11—ocular cancer	7.27e-05	0.000422	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HDAC1—ocular cancer	7.25e-05	0.000421	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CDKN2B—ocular cancer	7.23e-05	0.00042	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CDKN2B—ocular cancer	7.14e-05	0.000414	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HDAC1—ocular cancer	6.94e-05	0.000403	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—GNAQ—ocular cancer	6.76e-05	0.000392	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—E2F1—ocular cancer	6.64e-05	0.000385	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—E2F1—ocular cancer	6.55e-05	0.00038	CbGpPWpGaD
Dopamine—COMT—Metabolism—EP300—ocular cancer	6.54e-05	0.00038	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDKN2B—ocular cancer	6.5e-05	0.000377	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDKN2B—ocular cancer	6.22e-05	0.000361	CbGpPWpGaD
Dopamine—MAOB—Metabolism—EP300—ocular cancer	6.2e-05	0.00036	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HDAC1—ocular cancer	6.09e-05	0.000354	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MDM2—ocular cancer	6.04e-05	0.00035	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—E2F1—ocular cancer	5.97e-05	0.000346	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—E2F1—ocular cancer	5.71e-05	0.000331	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—HRAS—ocular cancer	5.61e-05	0.000326	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GNA11—ocular cancer	5.51e-05	0.00032	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CDKN1B—ocular cancer	5.51e-05	0.00032	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDKN2B—ocular cancer	5.46e-05	0.000317	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—AKT1—ocular cancer	5.45e-05	0.000317	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CCND1—ocular cancer	5.26e-05	0.000305	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—EP300—ocular cancer	5.25e-05	0.000305	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GNAQ—ocular cancer	5.13e-05	0.000298	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CDKN1A—ocular cancer	5.09e-05	0.000295	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GNA11—ocular cancer	5.07e-05	0.000294	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GNA11—ocular cancer	5.03e-05	0.000292	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—E2F1—ocular cancer	5.01e-05	0.000291	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—AKT1—ocular cancer	4.95e-05	0.000287	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EP300—ocular cancer	4.84e-05	0.000281	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GNAQ—ocular cancer	4.72e-05	0.000274	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GNAQ—ocular cancer	4.67e-05	0.000271	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MDM2—ocular cancer	4.66e-05	0.00027	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MDM2—ocular cancer	4.46e-05	0.000259	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—HRAS—ocular cancer	4.33e-05	0.000251	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GNA11—ocular cancer	4.3e-05	0.000249	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CDKN1B—ocular cancer	4.25e-05	0.000247	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MYC—ocular cancer	4.22e-05	0.000245	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TGFB1—ocular cancer	4.21e-05	0.000244	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—AKT1—ocular cancer	4.21e-05	0.000244	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—HRAS—ocular cancer	4.14e-05	0.00024	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.14e-05	0.00024	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CDKN1B—ocular cancer	4.07e-05	0.000236	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCND1—ocular cancer	4.06e-05	0.000235	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—AKT1—ocular cancer	4.03e-05	0.000234	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MDM2—ocular cancer	4.01e-05	0.000233	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GNAQ—ocular cancer	3.99e-05	0.000232	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MDM2—ocular cancer	3.96e-05	0.00023	CbGpPWpGaD
Dopamine—COMT—Metabolism—AKT1—ocular cancer	3.95e-05	0.000229	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CDKN1A—ocular cancer	3.92e-05	0.000228	CbGpPWpGaD
Dopamine—MAOA—Metabolism—EP300—ocular cancer	3.89e-05	0.000226	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCND1—ocular cancer	3.88e-05	0.000225	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—AKT1—ocular cancer	3.82e-05	0.000222	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.77e-05	0.000219	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CDKN1A—ocular cancer	3.76e-05	0.000218	CbGpPWpGaD
Dopamine—MAOB—Metabolism—AKT1—ocular cancer	3.75e-05	0.000218	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EP300—ocular cancer	3.73e-05	0.000217	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—HRAS—ocular cancer	3.73e-05	0.000216	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—HRAS—ocular cancer	3.68e-05	0.000213	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CDKN1B—ocular cancer	3.66e-05	0.000213	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—AKT1—ocular cancer	3.66e-05	0.000212	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—AKT1—ocular cancer	3.62e-05	0.00021	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CDKN1B—ocular cancer	3.61e-05	0.00021	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MDM2—ocular cancer	3.61e-05	0.000209	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—AKT1—ocular cancer	3.58e-05	0.000208	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EP300—ocular cancer	3.57e-05	0.000207	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCND1—ocular cancer	3.5e-05	0.000203	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—ocular cancer	3.47e-05	0.000201	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MDM2—ocular cancer	3.45e-05	0.0002	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCND1—ocular cancer	3.45e-05	0.0002	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CDKN1A—ocular cancer	3.38e-05	0.000196	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HRAS—ocular cancer	3.35e-05	0.000194	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CDKN1A—ocular cancer	3.34e-05	0.000194	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HRAS—ocular cancer	3.31e-05	0.000192	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDKN1B—ocular cancer	3.29e-05	0.000191	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—EP300—ocular cancer	3.29e-05	0.000191	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—AKT1—ocular cancer	3.29e-05	0.000191	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—AKT1—ocular cancer	3.26e-05	0.000189	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MYC—ocular cancer	3.25e-05	0.000189	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—AKT1—ocular cancer	3.25e-05	0.000188	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TGFB1—ocular cancer	3.25e-05	0.000188	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.22e-05	0.000187	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EP300—ocular cancer	3.22e-05	0.000187	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HRAS—ocular cancer	3.21e-05	0.000186	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EP300—ocular cancer	3.17e-05	0.000184	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—AKT1—ocular cancer	3.17e-05	0.000184	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDKN1B—ocular cancer	3.15e-05	0.000183	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCND1—ocular cancer	3.14e-05	0.000182	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—AKT1—ocular cancer	3.12e-05	0.000181	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MYC—ocular cancer	3.11e-05	0.000181	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TGFB1—ocular cancer	3.11e-05	0.00018	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—EP300—ocular cancer	3.07e-05	0.000178	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDKN1A—ocular cancer	3.04e-05	0.000176	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MDM2—ocular cancer	3.03e-05	0.000176	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCND1—ocular cancer	3.01e-05	0.000174	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—AKT1—ocular cancer	2.96e-05	0.000172	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—AKT1—ocular cancer	2.93e-05	0.00017	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDKN1A—ocular cancer	2.91e-05	0.000169	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EP300—ocular cancer	2.89e-05	0.000168	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—AKT1—ocular cancer	2.83e-05	0.000164	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HRAS—ocular cancer	2.81e-05	0.000163	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MYC—ocular cancer	2.8e-05	0.000163	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TGFB1—ocular cancer	2.8e-05	0.000162	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EP300—ocular cancer	2.77e-05	0.000161	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MYC—ocular cancer	2.77e-05	0.000161	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDKN1B—ocular cancer	2.77e-05	0.000161	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TGFB1—ocular cancer	2.76e-05	0.00016	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—AKT1—ocular cancer	2.74e-05	0.000159	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—ocular cancer	2.67e-05	0.000155	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCND1—ocular cancer	2.64e-05	0.000153	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—ocular cancer	2.56e-05	0.000148	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HRAS—ocular cancer	2.55e-05	0.000148	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDKN1A—ocular cancer	2.55e-05	0.000148	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MYC—ocular cancer	2.52e-05	0.000146	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TGFB1—ocular cancer	2.51e-05	0.000146	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—AKT1—ocular cancer	2.48e-05	0.000144	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HRAS—ocular cancer	2.45e-05	0.000142	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EP300—ocular cancer	2.43e-05	0.000141	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MYC—ocular cancer	2.41e-05	0.00014	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TGFB1—ocular cancer	2.4e-05	0.00014	CbGpPWpGaD
Dopamine—MAOA—Metabolism—AKT1—ocular cancer	2.35e-05	0.000137	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—ocular cancer	2.3e-05	0.000134	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—ocular cancer	2.27e-05	0.000132	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—AKT1—ocular cancer	2.26e-05	0.000131	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HRAS—ocular cancer	2.2e-05	0.000128	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HRAS—ocular cancer	2.17e-05	0.000126	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—AKT1—ocular cancer	2.16e-05	0.000125	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MYC—ocular cancer	2.12e-05	0.000123	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TGFB1—ocular cancer	2.11e-05	0.000123	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—ocular cancer	2.07e-05	0.00012	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—AKT1—ocular cancer	1.99e-05	0.000115	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—ocular cancer	1.98e-05	0.000115	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HRAS—ocular cancer	1.98e-05	0.000115	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—AKT1—ocular cancer	1.94e-05	0.000113	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—AKT1—ocular cancer	1.92e-05	0.000111	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HRAS—ocular cancer	1.89e-05	0.00011	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—AKT1—ocular cancer	1.85e-05	0.000108	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—EP300—ocular cancer	1.84e-05	0.000107	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—AKT1—ocular cancer	1.75e-05	0.000101	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—ocular cancer	1.74e-05	0.000101	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—EP300—ocular cancer	1.69e-05	9.83e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—EP300—ocular cancer	1.68e-05	9.75e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—AKT1—ocular cancer	1.67e-05	9.7e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HRAS—ocular cancer	1.66e-05	9.65e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AKT1—ocular cancer	1.47e-05	8.52e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—EP300—ocular cancer	1.44e-05	8.33e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—AKT1—ocular cancer	1.11e-05	6.46e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—AKT1—ocular cancer	1.02e-05	5.94e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—AKT1—ocular cancer	1.02e-05	5.89e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—AKT1—ocular cancer	8.67e-06	5.03e-05	CbGpPWpGaD
